HCPCS J7513 — Daclizumab, parenteral (2026 RVU Values)
HCPCS code J7513 (Daclizumab, parenteral) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
HCPCS code J7513 (Daclizumab, parenteral) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.